News

Solrikitug Emerges as a Promising Anti-TSLP Therapy for Severe Asthma, Poised to Address Critical Unmet Needs | DelveInsight
The RAINIER Study (NCT06496607) is an ongoing Phase IIa clinical trial investigating Solrikitug for adults with asthma. This randomized, double-blind, placebo-controlled study evaluates three dose ...
Zacks Small Cap Research on MSN23h
OTC Markets Hosts Virtual Investor Presentation with Pete O'Heeron, CEO & Chairman of FibroBiologics, Inc., with David Bautz, PhD, Senior Analyst at Zacks SCR
NASDAQ:FBLG Hello and welcome to Virtual Investor Conferences. On behalf of the Life Sciences Investor Forum and our co-host, Zacks Small Cap Research, we're very pleased you joined us for our ...